litlas
ログインアカウント作成

Wei‐Ting Hwang

2001–2025 年に発表

別表記
Wei-Ting Hwang
122
論文数
23,226
被引用数
74
h 指数
117
i10 指数

被引用数

Wei‐Ting Hwang の年別被引用数1991 年: 被引用 1 件2001 年: 被引用 3 件2002 年: 被引用 1 件2003 年: 被引用 5 件2004 年: 被引用 14 件2005 年: 被引用 18 件2006 年: 被引用 41 件2007 年: 被引用 66 件2008 年: 被引用 50 件2009 年: 被引用 88 件2010 年: 被引用 81 件2011 年: 被引用 74 件2012 年: 被引用 93 件2013 年: 被引用 94 件2014 年: 被引用 108 件2015 年: 被引用 185 件2016 年: 被引用 198 件2017 年: 被引用 220 件2018 年: 被引用 265 件2019 年: 被引用 839 件2020 年: 被引用 1,167 件2021 年: 被引用 1,193 件2022 年: 被引用 1,042 件2023 年: 被引用 784 件2024 年: 被引用 1,339 件2025 年: 被引用 839 件2026 年: 被引用 21 件1992〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,712 件、この内訳の 33.6%中国: 引用元論文 1,269 件、この内訳の 11.5%ドイツ: 引用元論文 609 件、この内訳の 5.5%イギリス: 引用元論文 545 件、この内訳の 4.9%イタリア: 引用元論文 410 件、この内訳の 3.7%カナダ: 引用元論文 401 件、この内訳の 3.6%フランス: 引用元論文 353 件、この内訳の 3.2%オーストラリア: 引用元論文 320 件、この内訳の 2.9%オランダ: 引用元論文 308 件、この内訳の 2.8%スペイン: 引用元論文 282 件、この内訳の 2.6%スイス: 引用元論文 261 件、この内訳の 2.4%日本: 引用元論文 219 件、この内訳の 2%
0%33.6%その他 21.3%

機関

分野

  • Medicine64.6%
  • Biochemistry, Genetics and Molecular Biology18.4%
  • Immunology and Microbiology7.3%
  • Psychology2.4%
  • Health Professions1.9%
  • Social Sciences1.8%
  • その他3.6%

トピック

  • CAR-T cell therapy research14.4%
  • Virus-based gene therapy research4.8%
  • Immune Cell Function and Interaction4.6%
  • CRISPR and Genetic Engineering3.9%
  • Cancer Immunotherapy and Biomarkers3.7%
  • Immunotherapy and Immune Responses3.6%
  • その他65%

共著者

全論文

検索で開く
  1. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

    著者: Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando, Iulian Pruteanu-Malinici, Mercy Gohil, Stefan Lundh, Alina C. Boesteanu, Yan Wang, Roddy S. O’Connor, Wei‐Ting Hwang, Edward Pequignot, David E Ambrose, Changfeng Zhang, Nicholas S. Wilcox, Felipe Bedoya, Corin L. Dorfmeier, Chen Fang, Lifeng Tian, Harit Parakandi, Minnal Gupta, Regina M. Young, F. Brad Johnson, Irina Kulikovskaya, Li Liu, Jun Xu, Sadik H. Kassim, Megan M. Davis, Bruce L. Levine, Noelle V. Frey, Donald L. Siegel, Alexander C. Huang, E. John Wherry, Hans Bitter, Jennifer L. Brogdon, David L. Porter, Carl H. June, J. Joseph Melenhorst - Nature Medicine 2018 被引用: 1,770

  2. CRISPR-engineered T cells in patients with refractory cancer

    著者: Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis, Adam D. Cohen, Kristy Weber, Eric Lancaster, Patricia Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen, Lifeng Tian, Vanessa Gonzalez, Jun Xu, In-Young Jung, J. Joseph Melenhorst, Gabriela Plesa, Joanne Shea, Tina Matlawski, Amanda Cervini, Avery L. Gaymon, Stephanie Desjardins, Anne Lamontagne, January Salas-McKee, Andrew D. Fesnak, Donald L. Siegel, Bruce L. Levine, Julie K. Jadlowsky, Regina M. Young, Anne Chew, Wei‐Ting Hwang, Elizabeth O. Hexner, Beatriz M. Carreno, Christopher L. Nobles, Frederic D. Bushman, Kevin R. Parker, Yanyan Qi, Ansuman T. Satpathy, Howard Y. Chang, Yangbing Zhao, Simon F. Lacey, Carl H. June - Science 2020 被引用: 1,484

  3. PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

    著者: Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, Simon F. Lacey, Andrew J. Rech, Megan M. Davis, Wei‐Ting Hwang, Priti Lal, Erica L. Carpenter, Shannon L. Maude, Gabriela Plesa, Neha Vapiwala, Anne Chew, Michael Moniak, Ronnie Sebro, Michael D. Farwell, Amy Marshall, Joan Gilmore, Lester Lledo, Karen Dengel, S. Church, Tyler Hether, Jun Xu, Mercy Gohil, Thomas H. Buckingham, Stephanie S. Yee, Vanessa Gonzalez, Irina Kulikovskaya, Fang Chen, Lifeng Tian, Kyle Tien, Whitney L. Gladney, Christopher L. Nobles, Hayley E. Raymond, Prostate Cancer Cellular Therapy Program Investigators, Diane Frazee, Mary Truran, Elizabeth Veloso, Holly McConville, Jonathan Aguedelo, Samantha Hower, Sophia Ngo, Julie K. Jadlowsky, J. Joseph Melenhorst, Aoife M. Roche, J.K. Everett, Minnal Gupta, Farzana Nazimuddin, Chelsie Bartoszek, Natalka Koterba, Rachael Reynolds, Farris Ellington, Christopher C. Kloss, Ji‐Hyun Lee, Yangbing Zhao, John Scholler, James L. Riley, Christina Bailey, Andrew J. P. White, Briana M. Hudson, Pearl Chang, Marcela V. Maus, Bruce L. Levine, Elizabeth O. Hexner, Donald L. Siegel, Frederic D. Bushman, Carl H. June, Joseph A. Fraietta, Naomi B. Haas - Nature Medicine 2022 被引用: 500

  4. Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

    著者: Stephen Bagley, Meghan Logun, Joseph A. Fraietta, Xin Wang, Arati Desai, Linda J. Bagley, Ali Nabavizadeh, Danuta Jarocha, Rene Martins, Eileen Maloney, Lester Lledo, Carly Stein, Amy Marshall, Rachel Leskowitz, Julie K. Jadlowsky, Shannon Christensen, Bike Su Oner, Gabriela Plesa, Andrea Brennan, Vanessa Gonzalez, Fang Chen, Yusha Sun, Whitney L. Gladney, David M. Barrett, MacLean P. Nasrallah, Wei‐Ting Hwang, Guo‐li Ming, Hongjun Song, Donald L. Siegel, Carl H. June, Elizabeth O. Hexner, Zev A. Binder, Donald M. O’Rourke - Nature Medicine 2024 被引用: 336

  5. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

    著者: David Porter, Wei‐Ting Hwang, Noelle V. Frey, Simon F. Lacey, Pamela A. Shaw, Alison W. Loren, Adam Bagg, Katherine T. Marcucci, Angela Shen, Vanessa Gonzalez, David E Ambrose, Stephan A. Grupp, Anne Chew, Zhaohui Zheng, Michael C. Milone, Bruce L. Levine, J. Joseph Melenhorst, Carl H. June - Science Translational Medicine 2015 被引用: 1,727

  6. B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma

    著者: Adam D. Cohen, Alfred L. Garfall, Edward A. Stadtmauer, J. Joseph Melenhorst, Simon F. Lacey, Eric Lancaster, Dan T. Vogl, Brendan M. Weiss, Karen Dengel, Annemarie Nelson, Gabriela Plesa, Fang Chen, Megan M. Davis, Wei‐Ting Hwang, Regina M. Young, Jennifer L. Brogdon, Randi Isaacs, Iulian Pruteanu-Malinici, Don L. Siegel, Bruce L. Levine, Carl H. June, Michael C. Milone - Journal of Clinical Investigation 2019 被引用: 790

  7. Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial

    著者: Stephen Bagley, Zev A. Binder, Lamia Lamrani, Eliana Marinari, Arati Desai, MacLean P. Nasrallah, Eileen Maloney, Steven Brem, Robert A. Lustig, Goldie Kurtz, Michelle Alonso‐Basanta, Pierre‐Emmanuel Bonté, Christel Goudot, Wilfrid Richer, Eliane Piaggio, Shawn Kothari, Léa Guyonnet, Coralie L. Guérin, Joshua J. Waterfall, Suyash Mohan, Wei‐Ting Hwang, Oliver Y. Tang, Meghan Logun, Meghna Bhattacharyya, Kelly Markowitz, Devora Delman, Amy Marshall, E. John Wherry, Sebastián Amigorena, Gregory L. Beatty, Jennifer L. Brogdon, Elizabeth O. Hexner, Denis Migliorini, Cécile Alanio, Donald M. O’Rourke - Nature Cancer 2024 被引用: 169

  8. Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients

    著者: Divij Mathew, Melina E. Marmarelis, Caitlin Foley, Joshua Bauml, Darwin Ye, Reem Ghinnagow, Shin Foong Ngiow, Max Klapholz, Soyeong Jun, Zhaojun Zhang, Robert Zorc, Christiana Davis, Maximillian Diehn, Josephine R. Giles, Alexander C. Huang, Wei‐Ting Hwang, Nancy R. Zhang, Adam J. Schoenfeld, Erica L. Carpenter, Corey J. Langer, E. John Wherry, Andy J. Minn - Science 2024 被引用: 207

  9. Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer

    著者: Charu Aggarwal, Jeffrey C. Thompson, Taylor A. Black, Sharyn I. Katz, Ryan Fan, Stephanie S. Yee, Austin L. Chien, Tracey L. Evans, Joshua Bauml, Evan Alley, Christine Ciunci, Abigail T. Berman, Roger B. Cohen, David Lieberman, Krishna S. Majmundar, Samantha L. Savitch, Jennifer J.D. Morrissette, Wei‐Ting Hwang, Kojo S.J. Elenitoba‐Johnson, Corey J. Langer, Erica L. Carpenter - JAMA Oncology 2018 被引用: 490

  10. Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV

    著者: Pablo Tebas, David Stein, Winson W. Tang, Ian Frank, Shelley Q. Wang, Gary Lee, S. Kaye Spratt, Richard Surosky, Martin Giedlin, Geoff Nichol, Michael C. Holmes, Philip D. Gregory, Dale Ando, Michael Kalos, Ronald G. Collman, Gwendolyn Binder-Scholl, Gabriela Plesa, Wei‐Ting Hwang, Bruce L. Levine, Carl H. June - New England Journal of Medicine 2014 被引用: 1,348

  11. T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma

    著者: Alfred L. Garfall, Ehren K. Dancy, Adam D. Cohen, Wei‐Ting Hwang, Joseph A. Fraietta, Megan M. Davis, Bruce L. Levine, Don L. Siegel, Edward A. Stadtmauer, Dan T. Vogl, Adam Waxman, Aaron P. Rapoport, Michael C. Milone, Carl H. June, J. Joseph Melenhorst - Blood Advances 2019 被引用: 229

  12. Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

    著者: Vijay Bhoj, Dimitrios C. Arhontoulis, Gerald Wertheim, James Capobianchi, Colleen Callahan, Christoph T. Ellebrecht, Amrom E. Obstfeld, Simon F. Lacey, J. Joseph Melenhorst, Farzana Nazimuddin, Wei‐Ting Hwang, Shannon L. Maude, Mariusz A. Wasik, Adam Bagg, Stephen J. Schuster, Michael D. Feldman, David L. Porter, Stephen Grupp, Carl H. June, Michael C. Milone - Blood 2016 被引用: 271

  13. Association Between Duration of Immunotherapy and Overall Survival in Advanced Non–Small Cell Lung Cancer

    著者: Lova Sun, Benjamin Aaron Bleiberg, Wei‐Ting Hwang, Melina E. Marmarelis, Corey J. Langer, Aditi P. Singh, Roger B. Cohen, Ronac Mamtani, Charu Aggarwal - JAMA Oncology 2023 被引用: 148

  14. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis

    著者: Wei‐Ting Hwang, Sarah F. Adams, Emin Tahirović, Ian S. Hagemann, George Coukos - Gynecologic Oncology 2011 被引用: 686

  15. Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia

    著者: Noelle V. Frey, Saar Gill, Elizabeth O. Hexner, Stephen J. Schuster, Sunita D. Nasta, Alison W. Loren, Jakub Svoboda, Edward A. Stadtmauer, Daniel J. Landsburg, Anthony R. Mato, Bruce L. Levine, Simon F. Lacey, J. Joseph Melenhorst, Elizabeth Veloso, Avery L. Gaymon, Edward Pequignot, Xinhe Shan, Wei‐Ting Hwang, Carl H. June, David L. Porter - Journal of Clinical Oncology 2020 被引用: 185

  16. C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

    著者: Stephanie L. Wethington, Payal D. Shah, Lainie P. Martin, János L. Tanyi, Nawar Latif, Mark A. Morgan, Drew A. Torigian, Diego Rodriguez, Simon A. Smith, Emma Dean, Susan M. Domchek, Ronny Drapkin, Ie‐Ming Shih, Eric J. Brown, Wei‐Ting Hwang, Deborah K. Armstrong, Stéphanie Gaillard, Robert Giuntoli, Fiona Simpkins - Clinical Cancer Research 2023 被引用: 77

  17. Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells

    著者: John Scholler, Troy Brady, Gwendolyn Binder-Scholl, Wei‐Ting Hwang, Gabriela Plesa, Kristen Hege, Ashley N. Vogel, Michael Kalos, James L. Riley, Steven G. Deeks, Ronald T. Mitsuyasu, Wendy B. Bernstein, Naomi Aronson, Bruce L. Levine, Frederic D. Bushman, Carl H. June - Science Translational Medicine 2012 被引用: 647

  18. Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia

    著者: Saar Gill, Vanessa Vides, Noelle V. Frey, Elizabeth O. Hexner, Susan Metzger, Megan A. O’Brien, Wei‐Ting Hwang, Jennifer L. Brogdon, Megan M. Davis, Joseph A. Fraietta, Avery L. Gaymon, Whitney L. Gladney, Simon F. Lacey, Anne Lamontagne, Anthony R. Mato, Marcela V. Maus, J. Joseph Melenhorst, Edward Pequignot, Marco Ruella, Maksim Shestov, John C. Byrd, Stephen J. Schuster, Donald L. Siegel, Bruce L. Levine, Carl H. June, David L. Porter - Blood Advances 2022 被引用: 126

  19. Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy

    著者: Alfred L. Garfall, Adam D. Cohen, Sandra P. Susanibar-Adaniya, Wei‐Ting Hwang, Dan T. Vogl, Adam Waxman, Simon F. Lacey, Vanessa Gonzalez, Joseph A. Fraietta, Minnal Gupta, Irina Kulikovskaya, Lifeng Tian, Fang Chen, Natalka Koterba, Robert L. Bartoszek, Margaret Patchin, Rong Xu, Gabriela Plesa, Don L. Siegel, Andrea Brennan, Anne Marie Nelson, Regina Ferthio, Angela Cosey, Kim-Marie Shea, Rachel Leskowitz, Megan Four, Wesley V. Wilson, Fei Miao, Eric Lancaster, Beatriz M. Carreno, Gerald P. Linette, Elizabeth O. Hexner, Regina M. Young, Dexiu Bu, Keith G. Mansfield, Jennifer L. Brogdon, Carl H. June, Michael C. Milone, Edward A. Stadtmauer - Blood Cancer Discovery 2022 被引用: 76

  20. Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer

    著者: Payal D. Shah, Stephanie L. Wethington, Cheyenne Pagan, Nawar Latif, János L. Tanyi, Lainie P. Martin, Mark A. Morgan, Robert A. Burger, Ashley Haggerty, Haley Zarrin, Diego Rodriguez, Susan M. Domchek, Ronny Drapkin, Ie−Ming Shih, Simon A. Smith, Emma Dean, Stéphanie Gaillard, Deborah K. Armstrong, Drew A. Torigian, Wei‐Ting Hwang, Robert Giuntoli, Fiona Simpkins - Gynecologic Oncology 2021 被引用: 117

  21. Cytokine-mediated CAR T therapy resistance in AML

    著者: Anand Bhagwat, Leonel Torres, Olga Shestova, Maksim Shestov, Patrick Mellors, Han R Fisher, Saamia Farooki, Benjamin F. Frost, Michael R. Loken, Avery L. Gaymon, Diane Frazee, Walter Rogal, Noelle V. Frey, Elizabeth O. Hexner, Selina M. Luger, Alison W. Loren, Mary Ellen Martin, Shannon R. McCurdy, Alexander E. Perl, Edward A. Stadtmauer, Jennifer L. Brogdon, Joseph A. Fraietta, Wei‐Ting Hwang, Don L. Siegel, Gabriela Plesa, Richard Aplenc, David L. Porter, Carl H. June, Saar Gill - Nature Medicine 2024 被引用: 81

  22. Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas

    著者: Peter A. Riedell, Wei‐Ting Hwang, Loretta J. Nastoupil, Martina Pennisi, Joseph P. McGuirk, Richard T. Maziarz, Veronika Bachanová, Olalekan O. Oluwole, Jamie Brower, Oscar A. Flores, Nausheen Ahmed, Levanto Schachter, Kharmen Bharucha, Bhagirathbhai Dholaria, Stephen J. Schuster, Miguel‐Angel Perales, Michael R. Bishop, David L. Porter - Transplantation and Cellular Therapy 2022 被引用: 77

  23. Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

    著者: Alfred L. Garfall, Marcela V. Maus, Wei‐Ting Hwang, Simon F. Lacey, Yolanda D. Mahnke, J. Joseph Melenhorst, Zhaohui Zheng, Dan T. Vogl, Adam D. Cohen, Brendan M. Weiss, Karen Dengel, Naseem Kerr, Adam Bagg, Bruce L. Levine, Carl H. June, Edward A. Stadtmauer - New England Journal of Medicine 2015 被引用: 638

  24. Carfilzomib-Associated Cardiovascular Adverse Events

    著者: Adam Waxman, Suparna C. Clasen, Wei‐Ting Hwang, Alfred L. Garfall, Dan T. Vogl, Joseph R. Carver, Rupal O’Quinn, Adam D. Cohen, Edward A. Stadtmauer, Bonnie Ky, Brendan M. Weiss - JAMA Oncology 2017 被引用: 276